Orgenesis Inc. /
Neurocords
Orgenesis purchases assets from Neurocords
What happened
Orgenesis Inc. acquired intellectual property assets and related development product, deliverables and data from Neurocords, LLC. The assets relate to advanced regenerative medicine therapies for spinal cord injuries.
Orgenesis Inc. will issue 1,200,000 shares of common stock as consideration.
The source
Everything on this page comes from the source below.
Orgenesis purchases assets from Neurocords
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly